HomeDVAX • NASDAQ
add
Dynavax Technologies Corp
Previous close
$12.36
Day range
$12.32 - $12.58
Year range
$9.74 - $15.01
Market cap
1.63B USD
Avg Volume
2.83M
P/E ratio
101.74
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 80.63M | 15.99% |
Operating expense | 41.53M | 13.25% |
Net income | 17.59M | 23.10% |
Net profit margin | 21.82 | 6.13% |
Earnings per share | 0.12 | 39.21% |
EBITDA | 13.47M | 86.48% |
Effective tax rate | 11.22% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 763.99M | 6.05% |
Total assets | 1.06B | 9.15% |
Total liabilities | 380.56M | 3.41% |
Total equity | 681.43M | — |
Shares outstanding | 131.45M | — |
Price to book | 2.38 | — |
Return on assets | 2.96% | — |
Return on capital | 3.35% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 17.59M | 23.10% |
Cash from operations | 19.47M | -37.46% |
Cash from investing | -15.46M | 85.42% |
Cash from financing | 2.48M | -17.30% |
Net change in cash | 6.84M | 109.47% |
Free cash flow | 12.51M | -49.59% |
About
CEO
Founded
1996
Headquarters
Website
Employees
408